SpectraWAVE, Inc. is a privately held medical device company founded in 2017 that focuses on enhancing the treatment and outcomes for patients with coronary artery disease (CAD). Their flagship product, the HyperVue™ Imaging System, integrates advanced imaging technologies to improve the decision-making process for interventionalists. The company aims to provide innovative optical and computational insights to optimize patient care in the cardiac catheterization lab. SpectraWAVE’s vision is to drive significant advancements in intravascular imaging to enhance clinical outcomes.